Pages that link to "Q34718444"

The following pages link to Did regulators fail over selective serotonin reuptake inhibitors? (Q34718444):

Displaying 25 items.

• Reporting bias in medical research - a narrative review (Q21203744) (← links)
• We need access to all data from all clinical trials (Q24235801) (← links)
• Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports (Q26773320) (← links)
• Why we need easy access to all data from all clinical trials and how to accomplish it (Q28732492) (← links)
• A comparison of adverse event and fracture efficacy data for strontium ranelate in regulatory documents and the publication record (Q30857985) (← links)
• Metareview on short-term effectiveness and safety of antidepressants for depression: an evidence-based approach to inform clinical practice. (Q33303429) (← links)
• Medicalization of global health 2: The medicalization of global mental health (Q33641459) (← links)
• Antidepressants and Suicide Risk: A Comprehensive Overview (Q33664712) (← links)
• Paroxetine: current status in psychiatry (Q36730643) (← links)
• New-generation antidepressants, suicide and depressed adolescents: how should clinicians respond to changing evidence? (Q37157631) (← links)
• Trussed in evidence? Ambiguities at the interface between clinical evidence and clinical practice (Q37416878) (← links)
• Health care frames - from Virchow to Obama and beyond: the changing frames in health care and their implications for patient care. (Q38259930) (← links)
• Our censored journals (Q38671313) (← links)
• Diagnosis - the limiting focus of taxonomy. (Q39248738) (← links)
• The future of conflicts of interest: a call for professional standards (Q39537482) (← links)
• Doctors as lapdogs to drug firms: the beast is ourselves (Q43177259) (← links)
• Are selective serotonin reuptake inhibitors a risk factor for adolescent suicide? (Q46103316) (← links)
• Media care and patient pressure (Q46977402) (← links)
• Cognitive behavioural therapy halves the risk of repeated suicide attempts: systematic review. (Q52958936) (← links)
• Evidentiary Support in Public Comments to the FDA's Center for Tobacco Products. (Q53305826) (← links)
• Recognizing, investigating and dealing with incomplete and biased reporting of clinical research: from Francis Bacon to the WHO (Q55055406) (← links)
• The use of mechanistic evidence in drug approval (Q57660586) (← links)
• Newer-Generation Antidepressants and Suicide Risk in Randomized Controlled Trials: A Re-Analysis of the FDA Database (Q72988757) (← links)
• Protecting the people?: risk communication and the chequered history and performance of bureaucracy (Q87436475) (← links)
• Reply to the Letter to the Editor: "Newer-Generation Antidepressants and Suicide Risk: Thoughts on Hengartner and Plöderl's Re-Analysis" (Q93125601) (← links)